Gilead Sciences, Inc. (GILD)
146.76
+0.64
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
146.50
-0.26
(-0.18%)
After-Hours: 20:00
Gilead Sciences Total Return Level : 212.96 for Aug. 21, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 21, 2026 | 212.96 |
| August 20, 2026 | 209.05 |
| August 19, 2026 | 215.12 |
| August 18, 2026 | 209.05 |
| August 17, 2026 | 202.47 |
| August 14, 2026 | 201.65 |
| August 13, 2026 | 201.33 |
| August 12, 2026 | 198.02 |
| August 11, 2026 | 197.88 |
| August 10, 2026 | 193.93 |
| August 07, 2026 | 194.14 |
| August 06, 2026 | 190.72 |
| August 05, 2026 | 192.03 |
| August 04, 2026 | 197.12 |
| August 03, 2026 | 191.14 |
| July 31, 2026 | 189.77 |
| July 30, 2026 | 191.33 |
| July 29, 2026 | 193.44 |
| July 28, 2026 | 195.76 |
| July 27, 2026 | 190.22 |
| July 24, 2026 | 188.46 |
| July 23, 2026 | 190.72 |
| July 22, 2026 | 189.96 |
| July 21, 2026 | 189.87 |
| July 20, 2026 | 194.14 |
| Date | Value |
|---|---|
| July 17, 2026 | 195.70 |
| July 16, 2026 | 198.65 |
| July 15, 2026 | 191.94 |
| July 14, 2026 | 189.52 |
| July 13, 2026 | 191.51 |
| July 10, 2026 | 189.22 |
| July 09, 2026 | 196.52 |
| July 08, 2026 | 197.95 |
| July 07, 2026 | 198.74 |
| July 06, 2026 | 188.90 |
| July 02, 2026 | 191.32 |
| July 01, 2026 | 183.59 |
| June 30, 2026 | 184.13 |
| June 29, 2026 | 184.12 |
| June 26, 2026 | 186.38 |
| June 25, 2026 | 180.49 |
| June 24, 2026 | 182.41 |
| June 23, 2026 | 182.25 |
| June 22, 2026 | 181.99 |
| June 18, 2026 | 180.37 |
| June 17, 2026 | 182.83 |
| June 16, 2026 | 185.43 |
| June 15, 2026 | 181.16 |
| June 12, 2026 | 181.84 |
| June 11, 2026 | 182.24 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Vertex Pharmaceuticals, Inc. | 548.05 |
| AbbVie, Inc. | 456.39 |
| Regeneron Pharmaceuticals, Inc. | 841.77 |
| Amgen, Inc. | 657.87 |
| Biogen, Inc. | 216.78 |